113 related articles for article (PubMed ID: 10647204)
21. Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling.
Morris JL; Zaman AG; Smyllie JH; Cowan JC
Br Heart J; 1995 Apr; 73(4):310-9. PubMed ID: 7756063
[TBL] [Abstract][Full Text] [Related]
22. Comments on 'A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina'.
Nyberg G
Int J Cardiol; 1997 Jun; 60(1):107-10. PubMed ID: 9209948
[No Abstract] [Full Text] [Related]
23. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
[TBL] [Abstract][Full Text] [Related]
24. The antianginal effect of isosorbide mononitrate.
Bassan M
Am J Cardiol; 1994 Jul; 74(1):103. PubMed ID: 8017298
[No Abstract] [Full Text] [Related]
25. Comparative efficacy of the intravenous administration of linsidomine, a direct nitric oxide donor, and isosorbide dinitrate in severe unstable angina. A French multicentre study. French Group of Investigators.
Delonca J; Giraud T; Beaufils P; Dupuis B; Haïat R; Théry C
Eur Heart J; 1997 Aug; 18(8):1300-6. PubMed ID: 9458423
[TBL] [Abstract][Full Text] [Related]
26. [Cardiological use of mononitrates].
Gurevich MA; Sanina NP; Buval'tsev VI
Klin Med (Mosk); 2000; 78(4):44-8. PubMed ID: 10833891
[TBL] [Abstract][Full Text] [Related]
27. [The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].
Blagodatskikh SV; Martsevich SIu; Metelitsa VI; Kutishenko NP; Kozyreva MP; Simkhaev LS; Slastinkova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1995; 58(3):25-7. PubMed ID: 7663289
[TBL] [Abstract][Full Text] [Related]
28. [Use of isosorbide-5-mononitrate in acute myocardial infarction].
Piegas LS; Timerman S; Timerman A; Gun C; Ramos RF; Romano ER; De Magalhães HM; Sousa JE
Arq Bras Cardiol; 1989 Mar; 52(3):167-72. PubMed ID: 2597005
[TBL] [Abstract][Full Text] [Related]
29. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
30. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
Schneider CA
Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
[No Abstract] [Full Text] [Related]
31. [ECG and BP monitoring in patients with stable angina and essential hypertension on therapy with monocinque].
Zaslavskaia RM; Shcherban' EA; Logvinenko SI
Klin Med (Mosk); 2005; 83(10):19-21. PubMed ID: 16320839
[TBL] [Abstract][Full Text] [Related]
32. [Time-dependent hemodynamic effects of monosan (Isosorbide-5-mononitrate) in anginal patients].
Zholdin BK; Zaslavskaia RM; Zhamankulov KA
Klin Med (Mosk); 1998; 76(4):30-2. PubMed ID: 9613078
[TBL] [Abstract][Full Text] [Related]
33. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction].
Lazebnik LB; Tereshchenko SN; Gendel'man AM
Kardiologiia; 1991 Oct; 31(10):13-5. PubMed ID: 1753569
[TBL] [Abstract][Full Text] [Related]
35. [Use of olicard retard in patients with stable angina of low effort in an outpatient setting].
Alekseeva NP; Runikhina NK; Lastovetskaia VI; Larin VG
Klin Med (Mosk); 2000; 78(8):72-4. PubMed ID: 11019532
[TBL] [Abstract][Full Text] [Related]
36. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
38. Is isosorbide mononitrate better than the dinitrate?
Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029
[No Abstract] [Full Text] [Related]
39. [Cardicap treatment of ischemic heart disease in aged patients].
Zaslavskaia RM; Goncharov LF; Reshniak LM
Klin Med (Mosk); 1997; 75(1):36-7. PubMed ID: 9082056
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
